...
首页> 外文期刊>Biopharmaceutics and Drug Disposition >Comparative bioavailability of josamycin, a macrolide antibiotic, from a tablet and solution and the influence of dissolution on in vivo release.
【24h】

Comparative bioavailability of josamycin, a macrolide antibiotic, from a tablet and solution and the influence of dissolution on in vivo release.

机译:乔沙霉素(一种大环内酯类抗生素)从片剂和溶液中的比较生物利用度以及溶出度对体内释放的影响。

获取原文
获取原文并翻译 | 示例

摘要

The bioavailability of josamycin from a tablet formulation (2 x Josacine 500 mg tablets) was investigated and compared with the bioavailability of a solution (containing 1 g drug and buffered at pH 4.0) following administration to six healthy human volunteers. Bioavailability profiles for the solution indicated that the drug was inherently rapidly absorbed with a mean Cmax of 1.64 +/- 0.67 mg L-1 attained at a mean tmax of 0.39 +/- 0.08 h. The AUC0-last was 1.510 +/- 0.687 mg h L-1. Bioavailability was significantly lower from the tablets than from the solution. Highly variable serum concentration-time profiles were obtained from the tablets and Cmax values ranged from 0.05 to 0.71 mg L-1 with a tmax range of 0.33-2.0 h. AUC0-last values ranged from 0.03 to 0.95 mg h L-1. Dissolution of josamycin from the tablets was generally unaffected at low pH (pH 1.2-5.0), but, rather, limited predominantly by tablet disintegration. However, dissolution was increasingly limited as the pH increased from 5.0 to 9.0. Besides poor disintegration, the particularly low intrinsic dissolution rate and solubility of josamycin at these pH values is likely to further reduce the dissolution rate. Comparison of the solution and tablet serum concentration-time profiles suggests that the absorption of josamycin from the tablets was dissolution rate limited. This is supported by the in vitro dissolution-pH topogram, which suggests that dissolution will be particularly rate limiting if dissolution of whole or parts of tablets occurs in gastro-intestinal fluid above pH 5.0.
机译:研究了片剂制剂(2片Josacine 500 mg片剂)中若沙霉素的生物利用度,并将其与溶液(含1 g药物并缓冲在pH 4.0下)的生物利用度进行比较,然后向六名健康人类志愿者给药。该溶液的生物利用度概况表明,该药物固有地快速吸收,平均Cmax为1.64 +/- 0.67 mg L-1,在tmax为0.39 +/- 0.08 h时达到。 AUC0-last为1.510 +/- 0.687 mg h L-1。片剂的生物利用度显着低于溶液。从片剂获得高度可变的血清浓度-时间曲线,Cmax值范围为0.05至0.71 mg L-1,tmax范围为0.33-2.0 h。 AUC0-last值介于0.03至0.95 mg h L-1之间。在低pH(pH 1.2-5.0)下,从片中溶出的沙沙霉素通常不会受到影响,但主要受片剂崩解的限制。然而,随着pH从5.0增​​加到9.0,溶解越来越受到限制。除了崩解性差之外,在这些pH值时,若沙霉素的固有溶解度和溶解度特别低,则可能会进一步降低溶解度。溶液和片剂的血清浓度-时间曲线的比较表明,从片剂中吸收丁香霉素的溶出速率受到限制。体外溶出度-pH拓扑图支持了这一点,这表明如果片剂的整体或部分溶出发生在pH 5.0以上的胃肠液中,溶出度将特别受速率限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号